To date, very few regulators worldwide have been able to resist this temptation.
The second step is to reorient risk assessment to focus on potential exposure to hazards that would produce an unacceptable level of risk. This should entail a solid predisposition for accelerating approval and adoption of novel products with a lower potential for unacceptable levels of risk compared to existing products. This will require that regulators evaluating new technologies resist the temptation to demand answers to questions that may be nice to know but have little or no utility for mitigating unreasonable risks—for example, requiring animal feeding safety trials to duplicate those already performed in other jurisdictions. To date, very few regulators worldwide have been able to resist this temptation. This must change.